{"date":"2026-01-21","count":3,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6864-2026-01-21-2222-19uxl11","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-01-21","time":"22:22:19","subject":"公告本公司獨立董事異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-01-21 22:22，「公告本公司獨立董事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-01-21-1826-oibpcj","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-21","time":"18:26:30","subject":"公告華上生醫自主開發新一代表觀免疫調控抗癌候選新藥GNTbm-38，取得新加坡發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-01-21 18:26，「公告華上生醫自主開發新一代表觀免疫調控抗癌候選新藥GNTbm-38，取得新加坡發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2026-01-21-1459-1gh3x3m","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2026-01-21","time":"14:59:58","subject":"公告本公司114年現金增資發行新股認股基準日等相關事宜(補充公告發行價格、代收及存儲價款行庫)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2026-01-21 14:59，「公告本公司114年現金增資發行新股認股基準日等相關事宜(補充公告發行價格、代收及存儲價款行庫)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}